Figure 1.

Identification of cellular processes associated with RBM3 expression in EOC. (A) Flowchart illustrating a novel approach to biomarker discovery whereby transcriptomic and proteomic data can be integrated to identify new biomarkers. (B) GSEA demonstrated that increased RBM3 expression was associated with a number of processes including DNA-dependent replication P < .01, chromatin remodeling P < .05, DNA replication P < .01, DNA integrity checkpoint P < .05, and DNA damage checkpoint P < .05.